semaglutide and heart issues Reverses Ectopic Lipid Accumulation, Impaired Myocardial Perfusion Reserve, Diastolic Dysfunction in a Mouse Model of Cardiometabolic Disease Semaglutide reduces major cardiovascular events

Research shows that this may also improve heart, liver, and lung function while helping to slow or prevent the effects of Alzheimers disease

Exendin-4 has been shown to reduce advanced glycation end product (AGE)-induced interleukin (IL)-6 and TNF- production, the expression of receptor for AGE (RAGE), and cell death in mesangial cells (Chang et al., 2017)

GLP-1 receptor agonists, including exenatide, liraglutide, tirzepatide and semaglutide, mimic the action of GLP-1 and have been approved by the Food and Drug Administration to treat Type 2 diabetes and obesity

Obesity alone has risen relentlessly over past decades, more than doubling in adults since 1990

Enrichment analysis of Tissues and CVDs was performed using Fishers exact tests on the Tissues 2.0 database (we selected the top 30% genes with the highest confidence of expression) and gene sets obtained from MeSH ( Visualization of ontological results of tissue association ontology and CVD analysis was performed in R using ggplot2 and ggrepel libraries

These enhancements were speculated to be a direct effect of liraglutide, rather than an effect of decreased blood glucose, which was achieved by dapagliflozin and acarbose [91]